Trial Details
COMPLETEDBasic Information
| Clinical ID | c3225 |
|---|---|
| Identifier | NCT02365649 |
| Trial Title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Placebo|DRUG: ABT-494 |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2015-03-17 |
|---|---|
| Primary Completion Date | 2016-11-25 |
| Completion Date | 2017-08-03 |